Epocrates IPO Review: Finance Trading Times

Epocrates IPO Review

More and more IPO filings are going on in the US markets. This time, a healthcare medical information provider company is planning to go public.

Epocrates is a provider of electronic medical info for healthcare practitioners. It is planning to come out with its IPO or initial public offering. The plans are to raise around 75 million USD through the Epocrates IPO.

What is the business of Epocrates?
Epocrates is in the business of providing medical information to doctors, hospitals and healthcare professionals in the electronic form. This is a business which is largely untapped, and has a lot of growth potential for future.
The company delivers clinical information and decision support tools to doctors, and places a heavy emphasis on mobile delivery. The service is designed for various handsets, including the iPhone and was one of the first companies to announce an iPhone application with Apple's blessing. An entire list of product offering from Epocrates is available on this link.

What is the amount of capital to be raised through Epocrates IPO?
The company expects to raise around 75 million USD through the Epocrates IPO.

Where will the shares be listed post Epocrates IPO
The share will be listed on NASDAQ stock exchange.

Related: Codexis IPO Review, American Water Workd IPO Review

What are the business valuations & financial results of Epocrates?
As per Washington Post, in 2007, the company had revenue of $65.6 million, up about 32 percent form the previous year. Net income was $7.3 million, compared to a loss of $4.3 million. In addition to its subscription services, the company also delivers sponsored content from marketers. Going forward, the company says, it plans to push its free content services more, diminishing the significance of subscriptions.

Who are the competitors of Epocrates?
Thomson Healthcare, Skyscape, & WebMD
The San Mateo, CA-based company was founded in 1998 and claims Sprout Group, Interwest Partners, Three Arch Partners, Draper Fisher Jurvetson, Bay City Capital and Goldman Sachs as investors. Table of Contents
Have Comments or Questions? Please post them as comments using "Post our Comments" link below. Your queries will be responded for free in 24 hrs!

0 Comments: Post your Comments

Wish you all happy and fruitful trading and investing activities with safety! = = = Post a Comment

Copyright Information:
© Finance-Trading-Times.com
Please see Our Copy Right Policy. All the articles, posts and other materials on this website/blog are copyrighted to the author of this site. The content should NOT to be reproduced on any other website or through other medium, without the author's permission. Contact: contactus(AT)finance-trading-times.com

DISCLAIMER: Before using this site, you agree to the Disclaimer. For Any questions or comments, please mail contactus(AT)finance-trading-times.com.

About UsAdvertise with UsCopyRight Policy & Fair Use GuidePrivacy PolicyDisclaimer